A bibliometric analysis of bladder cancer and microRNA research: Trends and advances from 2008 to 2022

Wei Zhang1, Gaowei Guo, Xinji Li

  • 1Department of Urology, Jieyang People's Hospital, Jieyang, Guangdong, P. R. China.

Medicine
|October 29, 2024
PubMed

Insights

This bibliometric analysis reveals a growing research trend in bladder cancer (BC) and microRNA (miRNA) studies. Key research areas include proliferation, biomarkers, and apoptosis, highlighting potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Bladder cancer (BC) presents a significant global health challenge with high incidence and mortality.
  • MicroRNAs (miRNAs) are critical regulators of gene expression, frequently dysregulated in BC.
  • Understanding miRNA roles in BC is vital for developing targeted therapies and improving patient outcomes.

Purpose of the Study:

  • To conduct a comprehensive bibliometric analysis of research on bladder cancer and microRNAs.
  • To examine the correlation between BC and miRNA research from 2008 to 2022.
  • To identify research hotspots, trends, and knowledge structures in this field.

Main Methods:

  • Bibliometric analysis of 798 articles from Web of Science Core Collection (2008-2022).
  • Utilized VOSviewer, Biblioshiny, and CiteSpace software for data analysis.
  • Co-citation analysis and keyword analysis were employed to map the research landscape.

Main Results:

  • A notable upward trend in publications from 2008 to 2019, with 21,233 total citations.
  • Seki Naohiko identified as the most productive author; China led in article volume.
  • High-frequency keywords included 'Proliferation,' 'Biomarkers,' and 'Apoptosis,' alongside 'Bladder cancer' and 'miRNA.'

Conclusions:

  • Research on bladder cancer and microRNAs is rapidly expanding globally.
  • Bibliometric analysis effectively identifies key research areas and collaboration patterns.
  • Further investigation into miRNA's role in BC, focusing on proliferation and apoptosis, is warranted for therapeutic advancements.